Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.
about
Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarraysStarved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor ProgressionDefining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsClinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.Bone marrow cell recruitment mediated by inducible nitric oxide synthase/stromal cell-derived factor-1alpha signaling repairs the acoustically damaged cochlear blood-labyrinth barrier.Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer.Do anesthetics and sampling strategies affect transcription analysis of fish tissues?Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth.Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas.Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer ProgressionClinical biomarkers for hypoxia targetingMyricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo.High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancerHIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD ConsortiumNicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathwaysCorrelations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilizationPrognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma.A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types.Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluationOxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis.A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells.Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer.Oxygen-mediated endocytosis in cancer.The tumor microenvironment in non-small-cell lung cancerNew biomarkers for lung cancer.Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors.Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors.Hypoxia inducible factor-1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study.Reduction of nitric oxide level enhances the radiosensitivity of hypoxic non-small cell lung cancer.Rapamycin decreases survivin expression to induce NSCLC cell apoptosis under hypoxia through inhibiting HIF-1α induction.Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells.Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer.[Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer.Cyclophilin A expression and its prognostic significance in lung adenocarcinoma.
P2860
Q24794295-36DE40C3-6298-40DA-ABFC-C5A0E4AE8E6AQ26767514-394F7BB6-5E07-4232-8A42-EF626809AF6FQ29615944-D507E919-8A7F-4960-BBEC-3990560E0DE3Q30249160-50B8BBB4-53B8-45E9-AE4E-5238D9EB2860Q30472457-260BCE12-59B2-475D-BA34-4AC22425453FQ33206782-7DEA8F11-325A-4E07-8535-5EEB4FE0C292Q33287226-74EE0018-BAAF-48B9-98C5-CB1AFBA6D0B4Q33385608-4E7A83A1-2C34-4D2D-9E11-146522111438Q33390467-5008F3D2-4CF8-4E5C-B2AF-2DA6D0F75F2FQ33588186-9707A126-001C-4607-844D-36003EEBA1CEQ33714638-D4862D4A-883B-4215-B100-2CF7F66D165EQ33829163-9140A00F-A258-47C6-A701-D5F4768629AFQ33903731-A08B83C9-3A1C-42B6-B68C-3AE503432FF6Q34198666-08B03CAD-E801-4B63-AF32-B561E2998573Q34199098-5E89AC12-D3E8-4C31-8047-334F91A8AFF6Q34371559-2A66F039-429A-4469-8182-C24C96EA2B08Q35059923-C592F985-C259-483C-8B09-619A37706A35Q35103188-66317769-5834-4DC0-9B42-5A1B4D347FB4Q35688354-3C9543F9-CDAE-499E-A57F-645399ED2202Q35770249-E5B37ECA-A542-4F6D-93A4-91AD8590E7DDQ35841917-BE9F6C37-5E72-4E7E-837B-F00824B5DBECQ36311791-313F59C5-C205-4345-A7CB-9E11271CEC41Q36389325-CDB69A60-6BEE-472B-BE08-C4B70CE18465Q36465299-CA69F7C6-EE0B-4226-A338-DBBC520B15AEQ37296289-21570EF0-2AA4-43E4-AF64-0EECCB7F07B7Q37777872-7AECE5AC-29A0-4217-A92B-8A1B68BE1273Q38089079-86B5F6CF-4F1A-4574-A3DF-FBB76982ABA0Q38177264-67B29103-C897-40B3-901B-ED54508083E9Q38821162-B7C4BA46-E121-4140-BAC3-684D8019E217Q38836322-6D2DD4F5-8ECF-4507-916A-BDF403C1541FQ39051622-746F4786-CA84-4A3E-B2E0-A3A70E9E6C7AQ39396957-5A0DA2BB-98C5-4833-8262-8990A367E3D4Q39478026-9178765A-4AEB-47DA-995E-00EDD2050DE4Q39543717-B442C2E7-9D03-4FB5-A3D2-BB08C9B6F283Q39739616-27AACCC7-E584-4055-AB1C-E086F98A5E0CQ39850353-6FCFEF7E-CB16-44EA-A3B0-FF99EB9196FBQ41454877-E0B4F7E0-B607-4F85-A48C-3263C7FDFF02Q44600102-0C863E9F-E61A-46A2-8B4D-B7F10A9F131DQ45886897-AE7D9B63-D511-47DD-98D7-FBB10192647FQ50062587-EFDEEEA2-F104-4490-84CC-8D8B3DBC1273
P2860
Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.
@ast
Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.
@en
type
label
Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.
@ast
Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.
@en
prefLabel
Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.
@ast
Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.
@en
P2093
P2860
P356
P1476
Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.
@en
P2093
Daniel E B Swinson
Donna Richardson
J Louise Jones
Kenneth J O'Byrne
P2860
P356
10.1002/IJC.20052
P577
2004-08-01T00:00:00Z